|
1
|
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
|
N Engl J Med
|
2002
|
24.07
|
|
2
|
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
|
Blood
|
2003
|
13.92
|
|
3
|
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
|
N Engl J Med
|
2004
|
12.20
|
|
4
|
WHO-EORTC classification for cutaneous lymphomas.
|
Blood
|
2005
|
12.14
|
|
5
|
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
|
Nature
|
2010
|
8.78
|
|
6
|
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
|
N Engl J Med
|
2010
|
8.74
|
|
7
|
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
|
Blood
|
2011
|
7.43
|
|
8
|
Oncogenically active MYD88 mutations in human lymphoma.
|
Nature
|
2010
|
7.34
|
|
9
|
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
|
Science
|
2008
|
6.52
|
|
10
|
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
|
Cancer Cell
|
2003
|
6.11
|
|
11
|
Molecular diagnosis of Burkitt's lymphoma.
|
N Engl J Med
|
2006
|
6.10
|
|
12
|
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
|
J Exp Med
|
2003
|
6.06
|
|
13
|
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
|
Proc Natl Acad Sci U S A
|
2008
|
5.90
|
|
14
|
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
|
N Engl J Med
|
2013
|
4.96
|
|
15
|
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.
|
Blood
|
2002
|
4.88
|
|
16
|
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
|
Blood
|
2008
|
4.62
|
|
17
|
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
|
Nature
|
2012
|
4.33
|
|
18
|
Bethesda proposals for classification of lymphoid neoplasms in mice.
|
Blood
|
2002
|
4.07
|
|
19
|
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
|
Clin Cancer Res
|
2009
|
3.87
|
|
20
|
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
|
J Clin Oncol
|
2012
|
3.59
|
|
21
|
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.
|
J Clin Oncol
|
2011
|
3.40
|
|
22
|
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.
|
Blood
|
2009
|
3.17
|
|
23
|
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma.
|
J Clin Oncol
|
2009
|
3.13
|
|
24
|
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
|
Blood
|
2005
|
3.12
|
|
25
|
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.
|
Blood
|
2006
|
2.90
|
|
26
|
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
|
Blood
|
2010
|
2.77
|
|
27
|
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
|
Blood
|
2009
|
2.73
|
|
28
|
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.
|
Blood
|
2011
|
2.64
|
|
29
|
Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.
|
Am J Surg Pathol
|
2004
|
2.58
|
|
30
|
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.
|
J Clin Oncol
|
2008
|
2.51
|
|
31
|
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
|
Blood
|
2003
|
2.46
|
|
32
|
Cooperative epigenetic modulation by cancer amplicon genes.
|
Cancer Cell
|
2010
|
2.43
|
|
33
|
Low-intensity therapy in adults with Burkitt's lymphoma.
|
N Engl J Med
|
2013
|
2.31
|
|
34
|
Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
|
Am J Surg Pathol
|
2004
|
2.30
|
|
35
|
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy.
|
Blood
|
2002
|
2.28
|
|
36
|
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.
|
Blood
|
2011
|
2.25
|
|
37
|
EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.
|
Am J Surg Pathol
|
2010
|
2.22
|
|
38
|
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
|
Am J Pathol
|
2004
|
2.20
|
|
39
|
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.
|
Blood
|
2005
|
2.19
|
|
40
|
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.
|
Blood
|
2008
|
2.15
|
|
41
|
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.
|
Blood
|
2004
|
2.13
|
|
42
|
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
|
Blood
|
2010
|
2.10
|
|
43
|
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
|
Blood
|
2010
|
2.09
|
|
44
|
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
|
J Clin Oncol
|
2006
|
2.02
|
|
45
|
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
|
Blood
|
2008
|
2.00
|
|
46
|
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma.
|
J Exp Med
|
2007
|
1.94
|
|
47
|
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.
|
J Clin Oncol
|
2013
|
1.91
|
|
48
|
Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
|
Blood
|
2014
|
1.88
|
|
49
|
NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series.
|
Blood
|
2010
|
1.83
|
|
50
|
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma.
|
Blood
|
2011
|
1.81
|
|
51
|
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas.
|
J Clin Oncol
|
2007
|
1.80
|
|
52
|
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
|
Blood
|
2012
|
1.79
|
|
53
|
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.
|
Haematologica
|
2009
|
1.79
|
|
54
|
Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
|
Am J Surg Pathol
|
2005
|
1.77
|
|
55
|
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.
|
Blood
|
2010
|
1.76
|
|
56
|
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
|
Blood
|
2011
|
1.72
|
|
57
|
Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
|
Histopathology
|
2013
|
1.71
|
|
58
|
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.
|
Blood
|
2013
|
1.71
|
|
59
|
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.
|
Blood
|
2014
|
1.71
|
|
60
|
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.
|
Cancer Discov
|
2014
|
1.70
|
|
61
|
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
|
Blood
|
2012
|
1.68
|
|
62
|
In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.
|
Blood
|
2002
|
1.68
|
|
63
|
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
|
Blood
|
2014
|
1.66
|
|
64
|
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.
|
Blood
|
2004
|
1.65
|
|
65
|
IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.
|
Am J Surg Pathol
|
2010
|
1.64
|
|
66
|
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma.
|
Nat Med
|
2005
|
1.63
|
|
67
|
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
|
Blood
|
2007
|
1.60
|
|
68
|
Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications.
|
Am J Surg Pathol
|
2010
|
1.59
|
|
69
|
Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma.
|
Blood
|
2011
|
1.58
|
|
70
|
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome.
|
Cancer Res
|
2009
|
1.58
|
|
71
|
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.
|
Blood
|
2006
|
1.58
|
|
72
|
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.
|
Blood
|
2011
|
1.57
|
|
73
|
Mycosis fungoides and Sézary syndrome.
|
Lancet
|
2008
|
1.54
|
|
74
|
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
|
J Clin Oncol
|
2012
|
1.53
|
|
75
|
Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma.
|
Blood
|
2003
|
1.52
|
|
76
|
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.
|
J Thorac Oncol
|
2015
|
1.50
|
|
77
|
Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus.
|
Leuk Lymphoma
|
2011
|
1.50
|
|
78
|
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
|
Blood
|
2009
|
1.46
|
|
79
|
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.
|
Leuk Lymphoma
|
2009
|
1.46
|
|
80
|
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.
|
Haematologica
|
2010
|
1.45
|
|
81
|
Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.
|
Leuk Lymphoma
|
2008
|
1.44
|
|
82
|
Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin.
|
Lancet Oncol
|
2004
|
1.41
|
|
83
|
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
|
J Clin Oncol
|
2007
|
1.39
|
|
84
|
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
|
Proc Natl Acad Sci U S A
|
2006
|
1.35
|
|
85
|
Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
|
Clin Cancer Res
|
2005
|
1.31
|
|
86
|
The pathology of NK-cell lymphomas and leukemias.
|
Adv Anat Pathol
|
2005
|
1.30
|
|
87
|
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.
|
Br J Haematol
|
2007
|
1.28
|
|
88
|
The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.
|
Cancer J
|
2012
|
1.26
|
|
89
|
Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
|
Am J Surg Pathol
|
2005
|
1.25
|
|
90
|
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
|
Haematologica
|
2011
|
1.22
|
|
91
|
Hodgkin lymphoma: an update on its biology with new insights into classification.
|
Clin Lymphoma Myeloma
|
2009
|
1.21
|
|
92
|
Peripheral T-cell lymphomas expressing CD30 and CD15.
|
Am J Surg Pathol
|
2003
|
1.21
|
|
93
|
Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis.
|
Lancet Oncol
|
2005
|
1.20
|
|
94
|
Plasmacytoid dendritic cells: physiologic roles and pathologic states.
|
Adv Anat Pathol
|
2009
|
1.19
|
|
95
|
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.
|
Blood
|
2005
|
1.19
|
|
96
|
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.
|
Lab Invest
|
2004
|
1.18
|
|
97
|
Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review.
|
Leuk Lymphoma
|
2004
|
1.17
|
|
98
|
The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity.
|
Blood
|
2002
|
1.17
|
|
99
|
Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.
|
Haematologica
|
2011
|
1.16
|
|
100
|
IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
|
Am J Surg Pathol
|
2007
|
1.14
|
|
101
|
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation.
|
Blood
|
2003
|
1.14
|
|
102
|
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features.
|
Mod Pathol
|
2010
|
1.14
|
|
103
|
Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.
|
Mod Pathol
|
2011
|
1.14
|
|
104
|
Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
|
Mod Pathol
|
2011
|
1.13
|
|
105
|
Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging.
|
Radiology
|
2005
|
1.13
|
|
106
|
Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.
|
Am J Surg Pathol
|
2010
|
1.12
|
|
107
|
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.
|
Blood
|
2008
|
1.12
|
|
108
|
Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.
|
Am J Surg Pathol
|
2008
|
1.12
|
|
109
|
Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma.
|
Haematologica
|
2008
|
1.11
|
|
110
|
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.
|
Curr Opin Hematol
|
2007
|
1.10
|
|
111
|
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report.
|
Haematologica
|
2009
|
1.08
|
|
112
|
Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow.
|
Cytometry B Clin Cytom
|
2005
|
1.08
|
|
113
|
Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.
|
Blood
|
2002
|
1.07
|
|
114
|
Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
|
J Natl Cancer Inst
|
2007
|
1.07
|
|
115
|
Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
|
Clin Cancer Res
|
2004
|
1.07
|
|
116
|
T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
|
Am J Surg Pathol
|
2002
|
1.06
|
|
117
|
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma.
|
Blood
|
2007
|
1.06
|
|
118
|
Marginal zone B-cell lymphoma in children and young adults.
|
Am J Surg Pathol
|
2003
|
1.05
|
|
119
|
Cutaneous gamma/delta T-cell lymphoma.
|
J Dtsch Dermatol Ges
|
2009
|
1.05
|
|
120
|
Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma.
|
Adv Anat Pathol
|
2004
|
1.05
|
|
121
|
Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential.
|
Pediatr Blood Cancer
|
2013
|
1.05
|
|
122
|
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.
|
Blood
|
2012
|
1.03
|
|
123
|
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma.
|
Blood
|
2006
|
1.03
|
|
124
|
Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens.
|
J Mol Diagn
|
2010
|
1.02
|
|
125
|
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
|
Blood
|
2011
|
1.02
|
|
126
|
Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues.
|
Clin Cancer Res
|
2011
|
1.00
|
|
127
|
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma.
|
Leuk Lymphoma
|
2005
|
1.00
|
|
128
|
Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
|
Mod Pathol
|
2003
|
0.99
|
|
129
|
Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases.
|
Haematologica
|
2009
|
0.99
|
|
130
|
Follicular lymphomas with plasmacytic differentiation include two subtypes.
|
Mod Pathol
|
2009
|
0.99
|
|
131
|
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.
|
Blood
|
2014
|
0.98
|
|
132
|
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.
|
Haematologica
|
2011
|
0.98
|
|
133
|
Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.
|
Am J Surg Pathol
|
2010
|
0.98
|
|
134
|
MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response.
|
Haematologica
|
2011
|
0.97
|
|
135
|
Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literature.
|
Leuk Lymphoma
|
2004
|
0.97
|
|
136
|
Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases.
|
Mod Pathol
|
2010
|
0.96
|
|
137
|
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
|
Blood
|
2013
|
0.96
|
|
138
|
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
|
Am J Hematol
|
2006
|
0.96
|
|
139
|
Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations.
|
Am J Surg Pathol
|
2015
|
0.95
|
|
140
|
Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma.
|
J Hematol Oncol
|
2009
|
0.95
|
|
141
|
The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006.
|
Pharmacoepidemiol Drug Saf
|
2011
|
0.95
|
|
142
|
Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.
|
Am J Surg Pathol
|
2011
|
0.95
|
|
143
|
Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.
|
Blood
|
2004
|
0.94
|
|
144
|
Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.
|
Am J Surg Pathol
|
2013
|
0.94
|
|
145
|
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.
|
Proc Natl Acad Sci U S A
|
2013
|
0.93
|
|
146
|
Lymphomatoid granulomatosis with involvement of the hard palate: a case report.
|
J Oral Maxillofac Surg
|
2008
|
0.93
|
|
147
|
Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events.
|
J Clin Immunol
|
2011
|
0.93
|
|
148
|
Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival.
|
Blood
|
2012
|
0.92
|
|
149
|
Early lesions of follicular lymphoma: a genetic perspective.
|
Haematologica
|
2013
|
0.92
|
|
150
|
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
|
Haematologica
|
2004
|
0.92
|
|
151
|
Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation.
|
J Clin Oncol
|
2012
|
0.92
|
|
152
|
Histopathology of Hodgkin's lymphoma.
|
Cancer J
|
2009
|
0.92
|
|
153
|
Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?
|
Curr Hematol Malig Rep
|
2011
|
0.92
|
|
154
|
CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression.
|
Haematologica
|
2009
|
0.92
|
|
155
|
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
|
Curr Hematol Malig Rep
|
2012
|
0.91
|
|
156
|
Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin.
|
Cancer Immunol Immunother
|
2002
|
0.91
|
|
157
|
HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease.
|
Blood
|
2002
|
0.91
|
|
158
|
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.
|
Am J Hematol
|
2012
|
0.90
|
|
159
|
Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR.
|
Mod Pathol
|
2010
|
0.90
|
|
160
|
Hairy cell leukemia diagnostic criteria and differential diagnosis.
|
Leuk Lymphoma
|
2011
|
0.89
|
|
161
|
Low-grade follicular lymphoma of the small intestine.
|
J Clin Gastroenterol
|
2002
|
0.88
|
|
162
|
Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.
|
J Hematop
|
2012
|
0.88
|
|
163
|
Frequent occurrence of deletions in primary mediastinal B-cell lymphoma.
|
Genes Chromosomes Cancer
|
2007
|
0.87
|
|
164
|
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.
|
PLoS One
|
2013
|
0.87
|
|
165
|
Solitary extramedullary plasmacytoma of the vocal cord in an adolescent.
|
J Clin Oncol
|
2009
|
0.87
|
|
166
|
IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
|
Am J Surg Pathol
|
2006
|
0.86
|
|
167
|
Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults.
|
Mod Pathol
|
2004
|
0.86
|
|
168
|
An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.
|
Am J Clin Pathol
|
2002
|
0.86
|
|
169
|
ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.
|
Mod Pathol
|
2013
|
0.86
|
|
170
|
Pathobiology of T-cell and NK-cell lymphomas.
|
Best Pract Res Clin Haematol
|
2013
|
0.85
|
|
171
|
Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies.
|
Am J Surg Pathol
|
2014
|
0.85
|
|
172
|
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.
|
J Clin Invest
|
2014
|
0.85
|
|
173
|
Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: implications for lymphomagenesis.
|
Leuk Lymphoma
|
2006
|
0.85
|
|
174
|
Nature and importance of follicular lymphoma precursors.
|
Haematologica
|
2014
|
0.85
|
|
175
|
A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?
|
Histopathology
|
2013
|
0.85
|
|
176
|
EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults.
|
Am J Surg Pathol
|
2014
|
0.85
|
|
177
|
Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome.
|
Am J Surg Pathol
|
2005
|
0.84
|
|
178
|
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2011
|
0.84
|
|
179
|
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival.
|
Blood
|
2013
|
0.84
|
|
180
|
Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
|
Am J Surg Pathol
|
2013
|
0.84
|
|
181
|
Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitis Is Associated with Epstein - Barr virus in the Setting of HIV Infection.
|
Infect Dis Clin Pract (Baltim Md)
|
2013
|
0.84
|
|
182
|
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.
|
Haematologica
|
2010
|
0.84
|
|
183
|
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.
|
Clin Lymphoma Myeloma Leuk
|
2011
|
0.84
|
|
184
|
Florid CD4+, CD56+ T-cell infiltrate associated with Herpes simplex infection simulating nasal NK-/T-cell lymphoma.
|
Mod Pathol
|
2003
|
0.83
|
|
185
|
T-cell/histiocyte-rich large B-cell lymphoma.
|
Haematologica
|
2010
|
0.83
|
|
186
|
Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis.
|
Am J Surg Pathol
|
2004
|
0.83
|
|
187
|
IgG4-related disease presenting as recurrent mastoiditis.
|
Laryngoscope
|
2012
|
0.82
|
|
188
|
Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
|
Pediatr Dev Pathol
|
2005
|
0.82
|
|
189
|
EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
|
Am J Surg Pathol
|
2017
|
0.82
|
|
190
|
Metachronous EBV-associated B-cell and T-cell posttransplant lymphoproliferative disorders in a heart transplant recipient.
|
Am J Surg Pathol
|
2009
|
0.81
|
|
191
|
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.
|
Clin Lymphoma
|
2005
|
0.81
|
|
192
|
Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease.
|
Am J Surg Pathol
|
2006
|
0.81
|
|
193
|
Automatic classification of lymphoma images with transform-based global features.
|
IEEE Trans Inf Technol Biomed
|
2010
|
0.81
|
|
194
|
Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis.
|
Blood
|
2004
|
0.81
|
|
195
|
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
|
Am J Surg Pathol
|
2016
|
0.81
|
|
196
|
CD5+ follicular lymphoma: a clinicopathologic study of three cases.
|
Am J Clin Pathol
|
2002
|
0.80
|
|
197
|
Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
|
Am J Surg Pathol
|
2012
|
0.80
|
|
198
|
Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids.
|
Clin Experiment Ophthalmol
|
2007
|
0.80
|
|
199
|
Follicular lymphomas: a tapestry of common and contrasting threads.
|
Haematologica
|
2013
|
0.80
|
|
200
|
Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.
|
Am J Surg Pathol
|
2011
|
0.79
|
|
201
|
Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma.
|
J Clin Oncol
|
2013
|
0.79
|
|
202
|
Why is it crucial to reintegrate pathology into cancer research?
|
Bioessays
|
2011
|
0.79
|
|
203
|
Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum.
|
J Invest Dermatol
|
2009
|
0.79
|
|
204
|
CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma.
|
Histopathology
|
2011
|
0.79
|
|
205
|
Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation.
|
J Natl Cancer Inst
|
2004
|
0.78
|
|
206
|
NUT rearrangement is uncommon in human thymic epithelial tumors.
|
J Thorac Oncol
|
2012
|
0.78
|
|
207
|
Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma.
|
J Clin Oncol
|
2003
|
0.78
|
|
208
|
Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (perforin 1).
|
J Clin Immunol
|
2015
|
0.77
|
|
209
|
Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue.
|
Methods Mol Biol
|
2010
|
0.77
|
|
210
|
Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
|
J Clin Oncol
|
2011
|
0.77
|
|
211
|
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.
|
Am J Surg Pathol
|
2015
|
0.77
|
|
212
|
Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.
|
Am J Surg Pathol
|
2011
|
0.76
|
|
213
|
Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma.
|
Am J Surg Pathol
|
2007
|
0.76
|
|
214
|
HHV-8-positive but EBV-negative primary effusion lymphoma.
|
Blood
|
2013
|
0.76
|
|
215
|
Molecular diagnostics.
|
Hematology Am Soc Hematol Educ Program
|
2003
|
0.76
|
|
216
|
Aggressive Epstein-Barr virus-associated, CD8+, CD30+, CD56+, surface CD3-, natural killer (NK)-like cytotoxic T-cell lymphoma.
|
Am J Surg Pathol
|
2002
|
0.76
|
|
217
|
Clonal Epstein-Barr virus-positive mucocutaneous ulcer mimicking a mature B-cell lymphoma in a patient with mycophenolate-induced immune suppression.
|
Leuk Lymphoma
|
2015
|
0.76
|
|
218
|
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1.
|
Am J Hematol
|
2008
|
0.75
|
|
219
|
Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.
|
Clin Lymphoma Myeloma Leuk
|
2013
|
0.75
|
|
220
|
Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.
|
J Clin Oncol
|
2011
|
0.75
|
|
221
|
Centralized review offers promise for the clinician, the pathologist, and the patient with newly diagnosed lymphoma.
|
J Clin Oncol
|
2011
|
0.75
|
|
222
|
Increased CD5-positive polyclonal B cells in Castleman disease: a diagnostic pitfall.
|
Histopathology
|
2013
|
0.75
|
|
223
|
What is anaplastic large cell lymphoma?
|
Am J Surg Pathol
|
2004
|
0.75
|
|
224
|
KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: New Findings and Review of the Literature.
|
Am J Surg Pathol
|
2017
|
0.75
|
|
225
|
Protocol for the examination of specimens from patients with hematopoietic neoplasms of the ocular adnexa.
|
Arch Pathol Lab Med
|
2010
|
0.75
|
|
226
|
Adrenal Hodgkin lymphoma.
|
Br J Haematol
|
2009
|
0.75
|
|
227
|
Nasal NK/T cell lymphoma mimicking a squamous cell carcinoma: a case report.
|
Indian J Pathol Microbiol
|
2005
|
0.75
|
|
228
|
Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms.
|
Arch Pathol Lab Med
|
2010
|
0.75
|
|
229
|
Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
|
J Cutan Pathol
|
2013
|
0.75
|
|
230
|
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.
|
Int J Cancer
|
2013
|
0.75
|
|
231
|
Clonally unrelated Hodgkin's disease following autologous stem cell transplant for B-cell lymphoma.
|
Br J Haematol
|
2002
|
0.75
|
|
232
|
Periodic fever with atypical dyshidrosis--quiz case.
|
Arch Dermatol
|
2004
|
0.75
|